Turning Point Therapeutics, Inc.
TPTX · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $290 | $310 | $428 | $404 |
| Short-Term Investments | $528 | $609 | $554 | $632 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $9 | $11 | $11 |
| Total Curr. Assets | $832 | $927 | $992 | $1,047 |
| Property Plant & Equip (Net) | $10 | $9 | $9 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $12 | $11 | $11 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $843 | $939 | $1,003 | $1,059 |
| Liabilities | – | – | – | – |
| Payables | $8 | $8 | $6 | $3 |
| Short-Term Debt | $4 | $4 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $37 | $34 | $38 | $32 |
| Total Curr. Liab. | $49 | $46 | $47 | $39 |
| LT Debt | $1 | $2 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $2 | $2 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $50 | $47 | $49 | $42 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$714 | -$591 | -$517 | -$438 |
| AOCI | -$7 | -$5 | -$1 | -$0 |
| Other Equity | $1,514 | $1,488 | $1,472 | $1,456 |
| Total Equity | $793 | $891 | $954 | $1,017 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $843 | $939 | $1,003 | $1,059 |
| Net Debt | -$285 | -$304 | -$422 | -$398 |